| answer text |
<p>The Antivirals and Therapeutics Taskforce is exploring options for a pilot study
to test antibody levels in immunosuppressed patients to provide clinical evidence
of a potential protective vaccine response. This could inform a wider testing programme
identifying those who have mounted a protective antibody response following vaccination
and provide more informed advice.</p><p>No specific cost estimate has yet been made.
However, officials are in discussions with experts in this area and further information
will be available in due course.</p>
|
 |
